Thalidomide-4-NH-PEG1-COOH TFA structure
|
Common Name | Thalidomide-4-NH-PEG1-COOH TFA | ||
|---|---|---|---|---|
| CAS Number | 2140807-20-9 | Molecular Weight | 503.38 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C20H20F3N3O9 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Thalidomide-4-NH-PEG1-COOH TFAThalidomide-4-NH-PEG1-COOH TFA is an E3 Ligase Ligand-Linker Conjugate consisting of Thalidomide (HY-14658) and NH-PEG3-NH-Boc. Thalidomide-4-NH-PEG1-COOH TFA acts as a ligand for Cereblon to recruit CRBN protein. Thalidomide-4-NH-PEG1-COOH TFA is a key intermediate in the synthesis of CRBN-based PROTAC molecules. |
| Name | Thalidomide-4-NH-PEG1-COOH TFA |
|---|
| Description | Thalidomide-4-NH-PEG1-COOH TFA is an E3 Ligase Ligand-Linker Conjugate consisting of Thalidomide (HY-14658) and NH-PEG3-NH-Boc. Thalidomide-4-NH-PEG1-COOH TFA acts as a ligand for Cereblon to recruit CRBN protein. Thalidomide-4-NH-PEG1-COOH TFA is a key intermediate in the synthesis of CRBN-based PROTAC molecules. |
|---|---|
| Related Catalog |
| Molecular Formula | C20H20F3N3O9 |
|---|---|
| Molecular Weight | 503.38 |